Thank you for getting in touch.
You will hear from us soon.
Connect with us
Are you interested in Bavarian Nordic´s CDMO services or you want to discuss your project with our experts? Please fill in the fields to get in touch with us.
Rutger Vandiest
Sr. Director - Head of Sales, CDMO
Bavarian Nordic
Who we are
A unique full-service biotech partner
for innovation and manufacturing of
GMO2/ BSL2 sterile liquid and
lyophilized products
WHAT WE CAN DO FOR YOU
We’re vaccine experts &
innovators who offer a wide
range of services
As innovators and developers of live virus vaccines, we are fully aware of the complexities and risks to getting product to market under the strictest of regulations. Our combination of expertise, state-of-the-art facility and technology, can guide and accelerate your biological therapeutics from pre-clinical to commercial stage and beyond while delivering the highest quality and reliable sterile products that improve the health and quality of life for children and adults.
Process development Formulation development Analytical development
Any drug development process must proceed through several stages in order to produce a product that is safe, efficacious, and has passed all regulatory requirements. Our scientists will assist you through all stages of CMC development and will help you to determine your testing needs. Our experienced staff can perform the critical tests and studies that are necessary to achieve regulatory approval.
Master seed virus Working seed virus
Our virus seed-banking processes and the BSL2 facility we use to manufacture your virus seed stocks are fully GMP compliant and offer high quality, stable and fully traceable starting material for GMP manufacturing of clinical and commercial products.
Pilot plant scale - Non GMP Clinical and commercial scale - GMP
Our talented people, well thought-through processes and comprehensive, validated equipment have been utilized in our BSL2 classified facility to fulfill numerous drug substance projects for preclinical, clinical and commercial supply.
Current Fill & Finish 2020 Fill & Finish
Today Bavarian Nordic offers fill and finish services using innovative technologies that are specifically designed to protect your biologic’s integrity and optimize yield of costly drug product. With a wealth of experience dealing with biologics, our scientists provide expertise across all areas of parenteral formulation and sterile manufacturing. By 2020 we will also provide large scale manufacturing, lyophilization and an integrated packaging line with serialization in our new fill and finish facility.
Quality Project management
We value the importance of product quality and compliance: Our objective is to be sure your product supply does not become the rate-limiting step for its overall development. Working with you from early stages of development to commercial scale/production, we will ensure that your product is of high quality and reaches your patients on time.
WHAT WE OFFER
Highlights of our currently
available fill and finish services
and looking ahead to 2020
Speaking as one biotech company to another, we appreciate the complexities of product development and manufacturing. By expanding our clinical and small scale commercial capabilities to a full commercial fill and finish facility with dedicated customer capacity, we will support you even further in bringing your valued products to your patients.
Why cdmo
“ Why CDMO? With 25 years of experience in R&D,
manufacturing and registration of live
virus vaccine products it’s about time
to expand our areas of business. ”
Henrik Birk
EVP, COO, Bavarian Nordic
3 REASONS TO CONTRACT WITH US
Why you should
consider us as your
trusted partner
01
EXPERTISE
& KNOWLEDGE
We´re experts working with live viruses and vaccines from discovery to development to manufacturing both for clinical and market supplies. Our reputation as a leading global vaccines provider is built on long-term collaborative relationships with government agencies and top-tier industry partners.
02
IN IT FOR
THE LONG RUN
As innovators and developers of live virus vaccines, we’re passionate about tackling diseases that really burden people’s lives. We have vaccines in clinical testing against a variety of advanced cancers and in serious infectious diseases.
03
READY TO
START TODAY
We’re invested in bringing our expertise, knowledge and passion to work for you by offering CDMO capabilities and services already today. By 2020 we also have a new large scale fill and finish facility where we can offer expanded BSL2 and lyophilization capacity.
DID YOU KNOW?
Come visit us at
PHARMAPACK
PARIS EXPO
6-7th February 2019
Porte de Versailles - Hall 7.2
Visit us at Stand H59
CPHI NORTH-AMERICA
April 30-May 2nd, 2019
McCormick Place - Chicago, Illinois
Visit us at booth 418
CPhI Worldwide
5-7th November 2019
Frankfurt, Germany
Visit us at booth 121G74
A global biotech company
We are a global
biotech company &
service provider
Bavarian Nordic is a global, fully vertically integrated biotechnology company focused on the research, development, manufacturing and marketing of innovative and safer vector-based vaccines against cancer and infectious diseases. Our goal is to improve the health and quality of life for children and adults, focusing on indications for which the unmet medical need is high and for which we can harness the power of the immune system to induce a response.
Denmark
Bavarian Nordic
Headquarter & Manufacturing
Hejreskovvej 10A
DK-3490 Kvistgaard,
Denmark
USA
Bavarian Nordic
Clinical Development
3025 Carrington Mill Boulevard
Morrisville NC 27560
USA
Germany
Bavarian Nordic
Research & Development
Fraunhoferstrasse 13
D-82152 Martinsried
Germany
Learn more about us
bavarian-nordic.com
We are always looking
for bright new talent.
View job openings